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Major histocompatibility complex class II positive
cells, namely dendritic cells, monocytes/macro-
phages, and B cells, are categorized as antigen-pre-
senting cells. Dendritic cells, so-called professional
antigen-presenting cells, use distinct sets of surface
receptors before and after maturation: those to cap-
ture antigens and those to interact with T cells,
respectively. But there remain many surface mol-
ecules whose functions are still unknown. In this
study, we isolated dendritic cell immunoreceptor
from mouse bone-marrow-derived mature dendritic
cells. Dendritic cell immunoreceptor is a recently
reported C-type lectin receptor characteristic with
cytoplasmic immunoreceptor tyrosine-based inhibi-
tory motif. Expression of mouse dendritic cell
immunoreceptor mRNA was observed speci®cally in
spleen and lymph node, slightly increased with den-
dritic cell maturation during in vitro culture of bone
marrow cells, and was not detected in cultured
natural killer cells. Surface expression of mouse den-
dritic cell immunoreceptor protein was observed in
splenic antigen-presenting cells including B cells,
monocytes/macrophages, and dendritic cells, but
not in T cells. To reveal the downregulating capacity
of dendritic cell immunoreceptor in antigen-present-
ing cells, the change of B-cell-receptor-mediated
signals after coligation with a chimeric Fcg receptor
IIB containing the cytoplasmic portion of mouse
dendritic cell immunoreceptor was examined. As a
result, we detected two distinct inhibitory effects of
cytoplasmic dendritic cell immunoreceptor ± inhib-
ition of B-cell-receptor-mediated Ca2+ mobilization
and protein tyrosine phosphorylation ± and both of
these effects required the tyrosine residue inside the
immunoreceptor tyrosine-based inhibitory motif.
This report presents immunoreceptor tyrosine-based
inhibitory motif-dependent negative regulatory
function of dendritic cell immunoreceptors. In con-
clusion, mouse dendritic cell immunoreceptor
expressed on antigen-presenting cells can exert two
distinct inhibitory signals depending on its immuno-
receptor tyrosine-based inhibitory motif tyrosine
residue. Key words: antigen-presenting cells/C-type lectin/
DCIR/dendritic cells/ITIM. J Invest Dermatol 118:261±
266, 2002
M
ajor histocompatibility complex (MHC) class II
positive cells, namely dendritic cells (DC),
monocytes/macrophages, and B cells, are cate-
gorized as antigen-presenting cells (APC).
Among them, DC form a system of bone-
marrow-derived ``professional'' APC specialized in interaction
with T cells (Banchereau and Steinman, 1998). Immature DC are
localized in peripheral tissues and function as sentinels. Once DC
capture antigens, they migrate into T cell areas of draining
lymphoid organs, become mature, and there present processed
antigenic peptides to T cells. Many surface receptors play distinct
roles in each aspect of DC functions. Among them, C-type (Ca2+-
dependent) lectin family receptors are considered to recognize
carbohydrate-bearing molecules using their carbohydrate recogni-
tion domain (CRD). Multiple (8±10) CRD-containing type I
membrane receptors, such as macrophage-mannose receptor (Stahl
and Ezekowitz, 1998) and DEC-205 (Jiang et al, 1995), are
reported to work in internalization of carbohydrate-bearing
antigens. In contrast various single CRD-containing type II
membrane receptors, most of which have been identi®ed in recent
years, are likely to have more complicated functions: langerin
works in antigen uptake (Valladeau et al, 2000); DC-SIGN acts as
an adhesion molecule (Geijtenbeek et al, 2000); and dectin-1 has a
costimulatory capacity (Ariizumi et al, 2000b).
The recently reported single CRD-containing type II receptor,
DC immunoreceptor (DCIR) (Bates et al, 1999), is distinct from
others by its cytoplasmic immunoreceptor tyrosine-based inhibi-
tory motif (ITIM) (Vivier and Daeron, 1997; Bolland and Ravetch,
1999). ITIM-bearing inhibitory receptors include two subgroups,
the Ig superfamily and the C-type lectin family. DCIR is the ®rst
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reported DC-expressing ITIM-bearing receptor of the C-type
lectin family. Its inhibitory function has been undetected so far,
however.
Here we describe the isolation and expression pro®le of mouse
DCIR and, furthermore, successfully show that its cytoplasmic
ITIM sequence does indeed deliver two distinct negative regulatory
signals in APC.
MATERIALS AND METHODS
Cells and mice Mouse bone-marrow-derived DC (BM-DC) were
prepared as described previously (Inaba et al, 1992). In brief, BALB/C
mouse bone marrow cells were cultured in the presence of recombinant
mouse granulocyte/macrophage colony-stimulating factor (GM-CSF) and
at day 6 the clusters of developing DC were transferred to a new plate
and recultured to allow maturation. In some experiments, 0.5 ng per ml
recombinant human transforming growth factor (TGF) b1 (R&D
Systems, Minneapolis, MN) was added to the DC culture after replating
at day 6. In order to prepare natural killer (NK) cells, C57BL/6 mouse
bone marrow cells were cultured in the presence of recombinant human
interleukin-15 (IL-15) (PeproTech EC, London, U.K.) as described
previously (Ogasawara et al, 1998). Collagenase (Wako Pure Chemical
Industries, Osaka, Japan) treated C57BL/6 mouse splenic cells were
prepared as described previously (Crowley et al, 1989). Flow cytometry
(FCM) analysis was performed using FACScan (Becton Dickinson,
Franklin Lakes, NJ). Some mice were intraperitoneally immunized with
1 3 108 sheep red blood cells (Cosmo Bio, Tokyo, Japan).
Nucleic acid analysis Construction of the cDNA library and
screening to isolate secretory pathway proteins using the signal sequence
trap (SST) method were performed as described previously (Jacobs et al,
1997). In brief, 5¢-enriched random-primed cDNA fragments were size-
fractionated and, after ampli®cation by polymerase chain reaction (PCR),
cloned into an expression vector bearing invertase cDNA without signal
sequence as a reporter. The library was introduced into SUC2± yeast
cells that could not survive without secretable invertase on the selection
plate and, after 3±7 d selection, surviving colonies were picked up and
base sequences of their plasmids were determined. After BLAST and
FASTA search, IMAGE consortium cDNA clones containing identical
expression-sequence tags were purchased and their base sequences were
determined. The cDNA fragment of DCIR (nucleotides 272±577)
labeled with [a-32P]dCTP was used as a probe for northern
hybridization. Reverse transcription (RT)-PCR was performed with the
following primer pairs: for DCIR, 5¢-GAT CTA AGA AAG CCT GGT
TC-3¢, 5¢-GCA AGA GAT ATC GTT CCA GC-3¢; for NKR-P1A,
5¢-TGA TGC ATC TCC TAT GCA C-3¢, 5¢-CAA TCT GTT GTT
TTA TTC AGG-3¢; for NKR-P1B, 5¢-GTC AAG TCC CTC CAT
CTA C-3¢, 5¢-CAA TCT GTT GTA TGT GTT CTG-3¢; for NKR-
P1C: 5¢-CTT CTC ACC ACC AGT TAA G-3¢, 5¢-GGC ACT CTA
AAT TAA CTG TTG-3¢. The conditions adapted for the Perkin-Elmer
9700 were described previously (Kanazawa et al, 1999).
Transformants The PCR-ampli®ed cDNA fragment of fractalkine
signal sequence (nucleotides 77±160 of GenBank AF071549) combined
with that of N-terminal histidine-tagged (six amino acids: HHHHHH)
mouse DCIR extracellular domain (nucleotides 485±991) for the soluble
form of DCIR, or that of full-length mouse DCIR (nucleotides 278±
991) with C-terminal FLAG epitope (eight amino acids: DYKDDDDK)
for membranous DCIR, was cloned into pCMX-PL1 expression vector
(Umesono et al, 1991) and transiently introduced into 293T cells (Numa
et al, 1995) using CellPhect Transfection Kit (Amersham Pharmacia
Biotech, Uppsala, Sweden). The PCR-ampli®ed cDNA fragment of
cytoplasmic mouse DCIR (nucleotides 278±508), its DY mutant
(nucleotide 297 A to T) or cytoplasmic CD72 (nucleotides 33±410 of
GenBank S40777), which were combined with that of C-terminal
FLAG-tagged extracellular Fcg receptor IIB (FcgRIIB; nucleotides 94±
612 of GenBank U51629), was cloned into retroviral pMX-IRES-EGFP
vector (Kitamura, 1998) and permanently introduced into IIA1.6 cells
(Jones et al, 1986) as described elsewhere.2 Green ¯uorescent protein
(GFP)-positive transformants were sorted using FACSVantage (Becton
Dickinson). Empty vector DNA was used as a negative control.
Antibodies Rabbit polyclonal antibodies were raised against two
polypeptides corresponding to the extracellular portions of mouse DCIR,
GHRQWQWVDQTPYEES and QSQEEQDFITGILDTH, and
af®nity-puri®ed with each peptide (Sawady Technologies, Tokyo, Japan).
Normal rabbit Ig (Dako Japan, Kyoto, Japan) was used as a negative
control. Horseradish peroxidase (HRP) conjugated anti-6xHis (Clontech
Laboratories, Palo Alto, CA), biotinylated anti-FLAG M2 (Sigma
Chemical, St. Louis, MO), intact or F(ab¢)2 fragment of rabbit antimouse
IgG (H + L) (Zymed, San Francisco, CA), and agarose or HRP-
conjugated antiphosphotyrosine (anti-PY) antibodies (Transduction
Laboratories, Lexington, KY) were purchased. Fluorescein isothiocyanate
(FITC) conjugated anti-CD3e, phycoerythrin (PE) conjugated anti-
NK1.1, B220, CD19, Mac1a, CD3e, I-A/I-E, or gd T cell receptor
(TCR), and biotinylated anti-CD11c, B7.1, or B7.2 antibodies were
purchased from PharMingen (San Diego, CA). As the secondary
antibodies, HRP-conjugated donkey antirabbit IgG (Amersham
Pharmacia Biotech), Texas Red (Vector Laboratories, Burlingame, CA),
or FITC-conjugated goat antirabbit IgG (H + L) antibodies (Jackson
Immunoresearch Laboratories, West Grove, PA), and FITC- or PE-
conjugated streptavidin (PharMingen) were used.
Calcium mobilization assay IIA1.6 transformants (8 3 106 cells per
ml) were loaded with 10 mM fura-red (Molecular Probes, Eugene, OR)
in 10 mM HEPES-containing medium at 37°C for 30 min, inverted
frequently. Collected cells were resuspended in the same medium
(1.6 3 106 cells per ml). After addition of 10 mg per ml antimouse IgG,
the cells were analyzed by FCM.
Immunoprecipitation IIA1.6 transformants (1.5 3 107 cells per ml)
were incubated with 25 mg per ml antimouse IgG at 37°C for 1 min
until addition of ice-cold phosphate-buffered saline. Preparation of cell
lysates was performed as described previously.2 Precleared lysates were
incubated with agarose-conjugated anti-PY at 4°C for 2 h.
Immunoprecipitates were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis and further provided for Western
blotting as described previously (Yabe et al, 1997).
RESULTS
Mouse DCIR is isolated from in vitro differentiated DC In
order to isolate soluble factors and their receptors expressed in DC,
we screened cDNA libraries constructed from TGF-b1 responsive
mouse BM-DC after 8 d culture using the SST method. Starting
from 106 independent cDNA clones, we picked up 520 surviving
yeast colonies, eliminated artifact clones, and ®nally obtained 24
independent genes. Known genes and counterparts of reported
genes in other species isolated by this study are listed in Table I.
Among them, we selected a clone that is identical to recently
discovered DCIR (C-type lectin, superfamily member 6; Clecsf6)
for further investigation and con®rmed its full-length cDNA
sequence (the nucleic acid sequence that we determined for mouse
DCIR has been submitted to GenBank under accession number
AF387099). Mouse DCIR is a type II membrane C-type lectin
receptor and the amino acid sequence of its CRD is the most
homologous to that of dectin-2, the recently identi®ed DC-speci®c
lectin (Ariizumi et al, 2000a), showing 48% identity, in contrast
with 55% between mouse and human DCIR. Furthermore, there
exist some other type II C-type lectins that are also highly
homologous to mouse DCIR and preferentially expressed in DC
and/or macrophages, such as macrophage-inducible C-type lectin
(42% identity; Matsumoto et al, 1999), macrophage-restricted C-
type lectin (38%; Balch et al, 1998), and macrophage calcium-type
lectin (33%; Mizuochi et al, 1997), as well as human DC-SIGN
(36%) and DC-SIGNR (37%; Soilleux et al, 2000). Among these
lectins, only DCIR bears cytoplasmic ITIM and has been predicted
to have a distinct inhibitory function (Bates et al, 1999).
Mouse DCIR is expressed on cultured mature DC but not
on NK cells Among normal tissues, mouse DCIR is speci®cally
expressed in spleen and lymph node, both tissues being rich in DC
(Fig 1a). Furthermore, the change of mouse DCIR expression
level during bone-marrow-derived DC differentiation was
examined by northern hybridization. As shown in Fig 1(b),
although DCIR expression was very faint in fresh bone marrow
cells, it became detectable after 4 d culture with GM-CSF, slightly
2Okazaki T, Macda A, Nishimura H, Kurosaki T, Honjo T. PD-1
immunoreceptor inhibits B cell receptor-mediated signaling by recruiting
scr homology 2-domain-containing tyrosine phosphatase 2 to phospho-
tyrosine. Proc Natl Acad Sci, USA (in press).
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increased with time, and reached a maximum on day 10. These
data suggest that mouse DCIR expression slightly increases with
DC maturation.
As the domain structure of DCIR, composed of cytoplasmic
ITIM and extracellular C-type lectin, was similar to that of NK cell
inhibitory receptors and the human DCIR gene is located close to
the NK gene complex (Bates et al, 1999), mouse DCIR expression
in NK cells was examined by RT-PCR. As shown in Fig 2(a),
after 10 d culture with IL-15, more than 90% of C57BL/6 mouse
bone marrow cells represent CD3± NK1.1+ NK cells. Although a
DCIR-speci®c band was detected in BM-DC, no expression of
DCIR was detected in these NK cells harvested on day 13, in
contrast to the strong expression of NK cell receptors such as
NKR-P1A, NKR-P1B, and NKR-P1C (Fig 2b).
Mouse DCIR protein is expressed on the surface of splenic
APC To observe the protein expression of mouse DCIR in vivo,
anti-DCIR polyclonal antibodies were raised and collagenase-
treated mouse splenocytes were analyzed by two-color FCM.
Speci®city of anti-DCIR antibodies was con®rmed by Western
blotting of the culture supernatant of 293T cells transfected with
the soluble form of DCIR (Fig 3a), by surface immunostaining of
293T cells transfected with membranous DCIR (Fig 3b), and
furthermore by FCM analysis of mouse splenocytes (Fig 4a). As
shown in Fig 4(b), almost all the B220+ or CD19+ B cells, Mac1+
monocytes/macrophages, and CD11c+ DC expressed DCIR,
whereas, in contrast, CD3+ T cells did not. It should be noted
that MHC class II was well coexpressed with DCIR (Fig 4b),
indicating that DCIR is unexceptionally expressed on the surface of
MHC class II+ APC including B cells, monocytes/macrophages,
and DC. B7.1+ or B7.2+ activated cells also expressed DCIR and,
after immunization, DCIR expression still remained high, in
accordance with the induction of B7.1 or B7.2 expression (Fig 4c).
Two independent antibodies speci®c for different portions of
DCIR gave the same results and representative results obtained
using antibodies against GHRQWQWVDQTPYEES are shown.
Table I. List of secretion pathway proteins isolated by the
yeast-SST from mouse TGF-b1 responsive BM-DC library.
Accesion no. Protein
Known
AB021289 epididymal secertory protein (ME1)
AF290973 lysosomal thiol reductase IP30
L20315 MPS1
M30655 phagocytic glycoprotein-1 (Pgp-1, CD44)
NM_008401 integrin alpha M (Itgam, CD11b)
NM_008526 lyphocyte antigen 55 complex, locus B (Ly55b,
NKR-P1B)
NM_009137 small inducible cytokine subfamily A, member 22
(Scya22, MDC)
NM_009263 secreted phosphoprotein 1 (Spp1, osteopontin)
NM_009976 cystatin C (Cst3)
NM_010299 GM2 ganglioside activator protein (Gm2a)
NM_010378 histocompatibility 2, class II antigen A, alpha
(H2-Aalpha)
NM_011113 urokinase plasminogen activator response (uPAR)
NM_011999 C-type lectin, superfamily member 6 (Clecsf6, DCIR)
NM_013532 glycoprotein 49 B (Gp49b)
NM_016898 CD164 antigen (MGC-24)
NM_017372 lysozyme (Lyzs)
NM_021334 integrin alpha X (Itgax, CD11c)
Counterparts
AB029028 human KIAA1105 protein
NM_006495 human ecotropic viral integration site 2B (EVI2B)
NM_014742 human KIAA0255 gene product
Figure 1. Mouse DCIR expression among normal tissues and
maturating DC. Total RNA was isolated from mouse normal tissues
(a) and bone-marrow-derived GM-CSF responsive DC harvested at day
0, 4, 6, 8, and 10 (b). DCIR mRNA level was determined by northern
hybridization. 18 mg total RNA was applied for each lane.
Figure 3. Speci®city of anti-DCIR antibodies. (a) Serum-free
culture supernatant of 293T cells transfected with the histidine-tagged
soluble form of DCIR was analyzed by Western blotting using anti-
6xHis (left column) or anti-DCIR antibodies (right column). (b) 293T cells
expressing FLAG-tagged full DCIR were stained with anti-FLAG (left
column) or anti-DCIR antibodies (right column) without permealyzation.
Figure 2. No expression of mouse DCIR in bone-marrow-
derived NK cells. (a) Flow diagram of CD3 and NK1.1 expression on
bone-marrow-derived NK cells cultured with IL-15 for 10 d. (b) Total
RNA (600 ng) from bone-marrow-derived NK cells and DC harvested
at days 13 and 8, respectively, was reverse transcribed using oligo-dT
primer. PCR was performed using speci®c primer pairs for NK cell
receptors or DCIR.
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DCIR engagement inhibits B cell receptor (BCR)-mediated
Ca2+ mobilization depending on its ITIM tyrosine To
reveal the inhibitory function of DCIR in APC, its engagement in
BCR-mediated activation signal was attempted. For this purpose, a
chimeric receptor containing cytoplasmic mouse DCIR and
extracellular FcgRIIB tagged by FLAG epitope in its C-terminus
(DCIR-FcR) was constructed and introduced into IIA1.6 cells
using the retroviral pMX-IRES-EGFP vector. IIA1.6 is a variant of
A20/2 J mouse B cell lymphoma lacking cell surface Fc receptors
(Jones et al, 1986). As illustrated in Fig 5(a), two other chimeric Fc
receptors were constructed and transfected: mutant DCIR-FcR
(DCIRDY-FcR), whose ITIM tyrosine at position 7 was replaced
with phenylalanine, and CD72-FcR including cytoplasmic CD72,
a well-investigated ITIM-bearing type II lectin receptor that can
negatively regulate signaling through BCR (Adachi et al, 2000).
Notably, as FcgRIIB is a type I membrane protein, the N-terminus
of extracellular FcgRIIB was close to the plasma membrane and it
stood reverse to its natural form. As shown in Fig 5(b), however,
sorted GFP-positive transformants were positively stained by anti-
gd TCR monoclonal antibody, whereas mock-transfected IIA1.6
cells of B cell origin were negatively stained, indicating that the
reverse form of extracellular FcgRIIB can be recognized by the Fc
portion of this antibody. The expression level of each chimeric FcR
on the surface of these transformants was almost the same among
these cells (Fig 5b). These transformants were stimulated using
F(ab¢)2 or intact antimouse IgG antibodies, resulting in ligation of
BCR only or coligation of BCR and chimeric FcR, respectively, as
illustrated in Fig 5(c).
We ®rst examined the effect of DCIR engagement in BCR-
mediated Ca2+ mobilization using fura-red as an indicator. After
ligation of BCR only, each transformant showed an immediate
decrease and gradual recovery of cellular fura-red (Fig 6, Mock
and BCR only), indicating transient rapid increase of intracellular
Ca2+ concentration (Burchiel et al, 2000). This Ca2+ mobilization
was fully inhibited when CD72-FcR was coligated with BCR
(Fig 6, CD72-FcR), indicating that cytoplasmic CD72 as a
positive control can deliver a negative regulatory signal using this
system. DCIR-FcR absolutely blocked the Ca2+ mobilization on
coligation with BCR to the same degree as CD72-FcR (Fig 6,
DCIR-FcR). These results reveal that engagement of cytoplasmic
DCIR can inhibit BCR-mediated Ca2+ mobilization, at least one
aspect of B cell activation, as is the case with cytoplasmic CD72.
Furthermore, this inhibition was completely lost when the ITIM
Figure 5. Production of IIA1.6 cells expressing chimeric FcR. (a)
Diagram of constructs: cytoplasmic and transmembrane domain of mouse
CD72, DCIR, and its DY mutant were fused with extracellular FcgRIIB
containing FLAG epitope in its C-terminus. (b) Cell surface expression
of chimeric FcR. Sorted GFP-positive transformants were analyzed by
two-color FCM using anti-TCR gd. (c) A schematic view of stimulation.
Incubation with intact antimouse IgG results in coligation of BCR and
chimeric FcR (left), whereas its F(ab¢)2 fragment results in ligation of
BCR only (right).
Figure 4. Mouse DCIR expression in splenic APC. (a) Collagenase-
treated mouse splenic cells were stained with anti-DCIR antibodies (thick
line) or the same amount of normal rabbit Ig (thin line). (b) Splenic cells
were analyzed by two-color FCM using anti-DCIR antibodies and each
leukocyte marker. (c) Flow diagram of DCIR and costimulatory
molecules before (left column) and 7 d after (right column) intraperitoneal
immunization with sheep red blood cells.
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tyrosine of DCIR was replaced with phenylalanine (Fig 6,
DCIRDY-FcR), indicating that the Ca2+-mobilization-inhibiting
effect of cytoplasmic DCIR is fully dependent on its ITIM tyrosine.
DCIR engagement inhibits BCR-mediated protein tyrosine
phosphorylation depending on its ITIM tyrosine As it is
known that BCR-mediated signal activates some kinase cascades
(Kurosaki, 1998; Tamir and Cambier, 1998), we further examined
the effect of DCIR engagement in BCR-mediated tyrosine
phosphorylation of various proteins with immunoprecipitation
and detection using anti-PY antibody. In Fig 7 (Mock), more
bands were visualized in lanes 2 and 3 than in lane 1 and they
showed a higher intensity, indicating that cellular tyrosine-
phosphorylated proteins increase both in number and in PY level
when only BCR is ligated in mock-transformants. In Fig 7
(DCIR-FcR), almost the same number of bands were visualized in
lane 5 as in lane 4 and they did not show much higher intensity
except for the 60 and 100 kDa bands, whereas in lane 6 there were
more bands and the bands were of higher intensity to the same
degree as those in lanes 2 and 3. These results indicate that BCR-
mediated protein tyrosine phosphorylation is remarkably inhibited
when DCIR-FcR is coligated with BCR. In contrast, in Fig 7
(DCIRDY-FcR), again more bands were visualized in lane 8 and
they showed a higher intensity than those in lane 7, to the same
degree as those in lane 9, indicating that BCR-mediated protein
tyrosine phosphorylation is fully recovered when the ITIM tyrosine
of DCIR is replaced with phenylalanine. These results demonstrate
that engagement of cytoplasmic DCIR can inhibit BCR-mediated
protein tyrosine phosphorylation depending on its ITIM tyrosine,
as is the case with inhibition of Ca2+ mobilization, revealing
another inhibitory effect of cytoplasmic DCIR through its ITIM.
DISCUSSION
In this study, we isolated mouse DCIR from BM-DC using the
SST method. DCIR is a type II membrane protein bearing a single
transmembrane domain near its N-terminus. The original SST
method using COS cells was reported to be useful for isolation of
secreted or type I membrane proteins bearing typical eukaryotic
signal sequences (Tashiro et al, 1993). As a result of the yeast-using
SST screening, however, which we performed in this study, about
10% of the clones obtained were type II proteins (Jacobs et al,
1997). The transmembrane region of DCIR, which contains more
amino acid residues and shows higher hydrophobicity than a typical
eukaryotic signal sequence, is considered to work as the secretory
signal sequence in this yeast-SST system. As human and mouse
DCIR were originally identi®ed by the database search (Bates et al,
1999), it should be noted that the DCIR was actually isolated from
the DC cDNA library. Recently, Bonkobara et al applied the
original SST method to isolation of novel proteins from
keratinocytes and reported some skin-speci®c molecules.3 These
results indicate that there still remain important molecules to be
identi®ed by the SST method in the dermatologic area as well as in
immunology.
We detected expression of mouse DCIR in spleen and lymph
node among normal tissues and splenic MHC class II+ APC
including DC, B cells, and monocytes/macrophages, but not in
cultured NK cells or splenic T cells (Figs 1a, 2b, 4b). These results
are quite consistent with those of the human counterpart (Bates et
al, 1999). In addition, we observed a slight increase of mouse
DCIR expression during in vitro culture of bone marrow cells with
GM-CSF, suggesting a slight increase of its expression with DC
maturation (Fig 1b). This observation is not necessarily consistent
with the previous report describing that expression of human
DCIR was downregulated with in vitro DC terminal maturation
induced by short-term culture with lipopolysaccharide or CD40
ligand after 7 d culture of blood monocytes with GM-CSF and IL-
4 (Bates et al, 1999). It remains to be further investigated whether
this discordance is due to the difference in species or the difference
in the method of induction of DC maturation, but the result of
FCM analysis showing that both mouse splenic B7.1high and
B7.2high cells retained a strong expression of DCIR after in vivo
immunization (Fig 4c) supports our in vitro observation.
Most interestingly, our results presented some lines of evidence
of the inhibitory DCIR function using a chimeric receptor
composed of cytoplasmic mouse DCIR and extracellular
FcgRIIB. FcgRIIB is one of the ITIM-bearing inhibitory receptors
of the Ig superfamily and has been examined intensively
(Coggeshall, 1998). When IgG is suf®ciently produced to form
immune complexes, FcgRIIB is coligated with BCR by this
complex and downmodulates the BCR-mediated activation signal,
resulting in negative feedback regulation of IgG production. This
in vivo phenomenon is reproduced in vitro by coligation of BCR
and FcgRIIB using anti-IgG antibody. Therefore, to investigate the
intracellular signaling pathway through other ITIM-bearing Ig
superfamily receptors, such as killer cell inhibitory receptors (Ono
et al, 1997; Bruhns et al, 1999) and PD-1,2 BCR-mediated signals
after coligation with a chimeric FcgRIIB containing their
cytoplasmic tail have been examined. In contrast, this study is the
Figure 7. ITIM-dependent inhibition of BCR-mediated protein
tyrosine phosphorylation by coligation of DCIR-FcR and BCR.
After stimulation, each transformant was lysed and immunoprecipitated
using anti-PY. Precipitates were analyzed by Western blotting using anti-
PY.
3Bonkobara M, Das A, Shikano S, Cruz P Jr, Ariizumi K: Effective use
of a signal-sequence-trap method to identify novel proteins secreted by
keratinocytes. J Invest Dermatol 114:806, 2000 (abstr.)
Figure 6. ITIM-dependent inhibition of BCR-mediated Ca2+
mobilization by coligation of DCIR-FcR and BCR. After
stimulation, change of fura-red level loaded in each transformant was
measured by FCM. Arrowheads indicate the timepoints of adding
antimouse IgG.
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®rst trial to coligate BCR with a chimeric receptor of cytoplasmic
ITIM-bearing type II receptor and extracellular FcgRIIB, in order
to reveal the inhibitory function of the type II receptor. As shown
in the results, the reverse form of extracellular FcgRIIB still works
as an Fc receptor (Fig 5b) and this system is useful to detect an
inhibitory effect delivered by a type II ITIM-bearing receptor such
as CD72 (Fig 6).
Using this method, we successfully showed a distinct inhibitory
effect of DCIR: DCIR engagement can downregulate BCR-
mediated Ca2+ mobilization as can CD72, and this effect requires
its ITIM tyrosine residue (Fig 6). Furthermore, we revealed that
DCIR engagement can downregulate BCR-mediated protein
tyrosine phosphorylation depending on its ITIM tyrosine residue
(Fig 7). This result reveals the second ITIM-dependent inhibitory
effect of DCIR and suggests involvement of some phosphatase in
DCIR-mediated inhibitory signal. The molecular mechanism of
inhibitory signal mediated by mouse DCIR, including phosphoryl-
ation of ITIM tyrosine and phosphatase recruitment, is now under
investigation. In a very recent report, human DCIR has been
shown to bind SH2-domain-containing protein tyrosine phospha-
tase 1 in myeloid HL-60 cells after pervanadate treatment (Huang et
al, 2001). Although the function of DCIR in the animal is still
unknown, the results we have presented in this study show
unexceptional expression of mouse DCIR in MHC class II+ APC
(Fig 4b) and its distinct downregulating capacity of B cell
activation signals (Figs 6, 7). It remains to be further investigated
whether DCIR can inhibit APC activation induced by anti-MHC
class II antibody as is the case with immunoglobulin-like transcript
3 (Cella et al, 1997), and whether DCIR regulates apoptosis like
CD72 and FcgRIIB (Ashman et al, 1996; Nomura et al, 1996).
Even its potential relevance to the pathophysiology of atopy or
allergic reactions should be proposed like other inhibitory receptors
(Scharenberg, 1999). Discovery of natural ligands or coreceptors of
DCIR, and phenotypic analysis of DCIR knockout mice or APC-
speci®c transgenic mice, may reveal its function in vivo.
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